The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage
Open accessAbstract
Hotspot mutations in the spliceosome gene SF3B1 are reported in ∼20% of uveal melanomas. SF3B1 is involved in 3′-splice site (3′ss) recognition during RNA splicing; however, the molecular mechanisms of its mutation have remained unclear. Here we show, using RNA-Seq analyses of uveal melanoma, that the SF3B1 R625/K666 mutation results in deregulated splicing at a subset of junctions, mostly by the use of alternative 3′ss. Modelling the differential junctions in SF3B1 WT and SF3B1 R625/K666 cell lines demonstrates that the deregulated splice pattern strictly depends on SF3B1 status and on the 3’ss-sequence context. SF3B1 WT knockdown or overexpression do not reproduce the SF3B1 R625/K666 splice pattern, qualifying SF3B1 R625/K666 as change-of-function mutants. Mutagenesis of predicted branchpoints reveals that the SF3B1 R625/K666 -promoted splice pattern is a direct result of alternative branchpoint usage. Altogether, this study provides a better understanding of the mechanisms underlying splicing alterations induced by mutant SF3B1 in cancer, and reveals a role for alternative branchpoints in disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
WebLogo: A Sequence Logo Generator: Figure 1
Crooks, G. E., Hon, G., Chandonia, J.-M., & Brenner, S. E. (2004) · Genome Research · doi:10.1101/gr.849004 · Cited by 12,386
The Spliceosome: Design Principles of a Dynamic RNP Machine
Wahl, M. C., Will, C. L., & Lührmann, R. (2009) · Cell · doi:10.1016/j.cell.2009.02.009 · Cited by 2,665
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Desmet, F.-O., Hamroun, D., Lalande, M., Collod-Béroud, G., Claustres, M., & Béroud, C. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp215 · Cited by 2,512
Frequent pathway mutations of splicing machinery in myelodysplasia
Yoshida, K., Sanada, M., Shiraishi, Y., Nowak, D., Nagata, Y., Yamamoto, R., Sato, Y., Sato-Otsubo, A., Kon, A., Nagasaki, M., et al. (2011) · Nature · doi:10.1038/nature10496 · Cited by 2,029
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Wang, L., Lawrence, M. S., Wan, Y., Stojanov, P., Sougnez, C., Stevenson, K., Werner, L., Sivachenko, A., DeLuca, D. S., Zhang, L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1109016 · Cited by 1,080
Quesada, V., Conde, L., Villamor, N., Ordóñez, G. R., Jares, P., Bassaganyas, L., Ramsay, A. J., Beà, S., Pinyol, M., Martínez-Trillos, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.1032 · Cited by 996
Martin, M., Maßhöfer, L., Temming, P., Rahmann, S., Metz, C., Bornfeld, N., van de Nes, J., Klein-Hitpass, L., Hinnebusch, A. G., Horsthemke, B., et al. (2013) · Nature Genetics · doi:10.1038/ng.2674 · Cited by 542
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
Harbour, J. W., Roberson, E. D. O., Anbunathan, H., Onken, M. D., Worley, L. A., & Bowcock, A. M. (2013) · Nature Genetics · doi:10.1038/ng.2523 · Cited by 516
Functional recognition of the 3′ splice site AG by the splicing factor U2AF35
Wu, S., Romfo, C. M., Nilsen, T. W., & Green, M. R. (1999) · Nature · doi:10.1038/45590 · Cited by 457
Darman, R. B., Seiler, M., Agrawal, A. A., Lim, K. H., Peng, S., Aird, D., Bailey, S. L., Bhavsar, E. B., Chan, B., Colla, S., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.053 · Cited by 453
SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
Furney, S. J., Pedersen, M., Gentien, D., Dumont, A. G., Rapinat, A., Desjardins, L., Turajlic, S., Piperno-Neumann, S., de la Grange, P., Roman-Roman, S., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0330 · Cited by 434
Self-citationThe spliceosome as a target of novel antitumour drugs
Bonnal, S., Vigevani, L., & Valcárcel, J. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3823 · Cited by 405
Misregulation of Pre-mRNA Alternative Splicing in Cancer
Zhang, J., & Manley, J. L. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0253 · Cited by 307
A Potential Role for U2AF-SAP 155 Interactions in Recruiting U2 snRNP to the Branch Site
Gozani, O., Potashkin, J., & Reed, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.8.4752 · Cited by 298
Corrionero, A., Miñana, B., & Valcárcel, J. (2011) · Genes & Development · doi:10.1101/gad.2014311 · Cited by 263
Genome-wide discovery of human splicing branchpoints
Mercer, T. R., Clark, M. B., Andersen, S. B., Brunck, M. E., Haerty, W., Crawford, J., Taft, R. J., Nielsen, L. K., Dinger, M. E., & Mattick, J. S. (2015) · Genome Research · doi:10.1101/gr.182899.114 · Cited by 251
Genome-Wide Association between Branch Point Properties and Alternative Splicing
Corvelo, A., Hallegger, M., Smith, C. W. J., & Eyras, E. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001016 · Cited by 231
DeBoever, C., Ghia, E. M., Shepard, P. J., Rassenti, L., Barrett, C. L., Jepsen, K., Jamieson, C. H. M., Carson, D., Kipps, T. J., & Frazer, K. A. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004105 · Cited by 211
Mechanisms for U2AF to define 3′ splice sites and regulate alternative splicing in the human genome
Shao, C., Yang, B., Wu, T., Huang, J., Tang, P., Zhou, Y., Zhou, J., Qiu, J., Jiang, L., Li, H., et al. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2906 · Cited by 182
SF3B1 mutations constitute a novel therapeutic target in breast cancer
Maguire, S. L., Leonidou, A., Wai, P., Marchiò, C., Ng, C. K., Sapino, A., Salomon, A., Reis‐Filho, J. S., Weigelt, B., & Natrajan, R. C. (2015) · The Journal of Pathology · doi:10.1002/path.4483 · Cited by 175
Amirouchene-Angelozzi, N., Nemati, F., Gentien, D., Nicolas, A., Dumont, A., Carita, G., Camonis, J., Desjardins, L., Cassoux, N., Piperno-Neumann, S., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.06.004 · Cited by 166
Self-citationGuth, S., Martínez, C., Gaur, R. K., & Valcárcel, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8263 · Cited by 89
Norton, P. A. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.19.3854 · Cited by 76
Crystal structure of a core spliceosomal protein interface
Schellenberg, M. J., Edwards, R. A., Ritchie, D. B., Kent, O. A., Golas, M. M., Stark, H., Lührmann, R., Glover, J. N. M., & MacMillan, A. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508048103 · Cited by 76
Dual Function for U2AF 35 in AG-Dependent Pre-mRNA Splicing
Guth, S., Tange, T. Ø., Kellenberger, E., & Valcárcel, J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.22.7673-7681.2001 · Cited by 75
Khan, S. G. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh026 · Cited by 65
In Vivo Requirement of the Small Subunit of U2AF for Recognition of a Weak 3′ Splice Site
Pacheco, T. R., Coelho, M. B., Desterro, J. M. P., Mollet, I. G., & Carmo‐Fonseca, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00350-06 · Cited by 61
Rare SF3B1 R625 mutations in cutaneous melanoma
Kong, Y., Krauthammer, M. O., & Halaban, R. (2014) · Melanoma Research · doi:10.1097/cmr.0000000000000071 · Cited by 60
Perturbation of U2AF65/NXF1-mediated RNA nuclear export enhances RNA toxicity in polyQ diseases
Tsoi, H., Lau, T. C., Lau, K., & Chan, H. Y. E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr297 · Cited by 48
Gentien, D., Kosmider, O., Nguyen‐Khac, F., Albaud, B., Rapinat, A., Dumont, A. G., Damm, F., Popova, T. G., Marais, R., Fontenay, M., et al. (2014) · Leukemia · doi:10.1038/leu.2014.28 · Cited by 33
Self-citation
Cited by
U1 snRNP regulates cancer cell migration and invasion in vitro
Oh, J.-M., Venters, C. C., Di, C., Pinto, A. M., Wan, L., Younis, I., Cai, Z., Arai, C., So, B. R., Duan, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13993-7 · Cited by 7,157
Neoantigens: promising targets for cancer therapy
Xie, N., Shen, G., Gao, W., Huang, Z., Huang, C., & Fu, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01270-x · Cited by 1,020
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Kahles, A., Lehmann, K.-V., Toussaint, N. C., Hüser, M., Stark, S. G., Sachsenberg, T., Stegle, O., Kohlbacher, O., Sander, C., Caesar-Johnson, S. J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.07.001 · Cited by 897
Self-citationIntegrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
Robertson, A. G., Shih, J., Yau, C., Gibb, E. A., Oba, J., Mungall, K. L., Hess, J. M., Uzunangelov, V., Walter, V., Danilova, L., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.003 · Cited by 887
Self-citationJager, M. J., Shields, C. L., Cebulla, C. M., Abdel-Rahman, M. H., Grossniklaus, H. E., Stern, M.-H., Carvajal, R. D., Belfort, R. N., Jia, R., Shields, J. A., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0158-0 · Cited by 825
Self-citation
Metadata
- Authors
- Alsafadi, S., Houy, A., Battistella, A., Popova, T., Wassef, M., Henry, E., Tirode, F., Constantinou, A., Piperno-Neumann, S., Roman-Roman, S., Dutertre, M., & Stern, M.-H.
- Venue
- Nature Communications
- Published
- 2016-02-04
- Volume
- 7
- Issue
- 1
- Pages
- 10615-10615
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2413340136
- Cited by
- 386
- References
- 32
- FWCI
- 21.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.